NCT00401427View on ClinicalTrials.gov

HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2006

Study Completion Date

December 31, 2006

Conditions
Metastatic Breast Cancer
Interventions
DRUG

trastuzumab

DRUG

vinorelbine

All Listed Sponsors
lead

National Cancer Institute, Naples

OTHER

NCT00401427 - HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter